Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-008609
Filing Date
2025-03-19
Accepted
2025-03-19 17:42:50
Documents
1
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 form4-03192025_090346.html 4  
1 form4-03192025_090346.xml 4 4066
  Complete submission text file 0001415889-25-008609.txt   5550
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ENLIVEN THERAPEUTICS INC 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address
Kintz Samuel (Reporting) CIK: 0001967168 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 25753878